Aurobindo's Generic Ramelteon Receives Approval in the U.S.
Xiromed's Generic Ramelteon Receives Approval in the U.S.
Enaltec's Generic Ramelteon Receives Approval in the U.S.
Granules India traded broadly on a positive note on Monday, as the company's wholly-owned subsidiary bagged USFDA approval for Ramelteon tablet.
Granules Pharmaceuticals, Inc (GPI)., a wholly owned foreign subsidiary of Granules India Limited has received US Food & Drug Administration (FDA) approval for ramelteon tablets, 8 mg.
Granules Pharma`s Generic Ramelteon Receives Approval In US
Zydus Cadila launches insomnia drug in US market
Zydus Pharms USA`s Generic Ramelteon Receives Approval in US
New insomnia medication approved
8 Invented Diseases Big Pharma Is Banking On